From: Prevalence of co-morbid depression in out-patients with type 2 diabetes mellitus in Bangladesh
Category | Total Sample | Sylheti speakers | Bengali speakers |
---|---|---|---|
Total approached for screening (n) | 483 | 220 | 263 |
Total recruited and taken part % (n) | 86 (417/483) | 45 (189/417) | 55 (228/417) |
Hospital | Â | Â | Â |
BIRDEM, Dhaka % (n) | 40.3 (168/417) | 21 (35/168) | 79 (133/168 |
NHN, Dhaka % (n) | 20.6 (86/417) | 14 (12/86) | 86 (74/86) |
BADAS Hospital Sylhet % (n) | 39 (163/417) | 87 (142/163) | 13 (21/163) |
Current Age (Mean ± SD) | 53.2 (7.6) | 53.9 (8.2) | 53 (6.9) |
% (n) Female | 49.4 (206/417) | 47 (89/189) | 51 (117/228) |
Monthly income in Taka a | 9684 ± 6265 | 9376 ± 6096 | 9873 ± 6497 |
% (n) on insulin treatment | 35 (145/417) | 40 (75/189) | 31 (70/228) |
Duration of Insulin Treatment (in years) (Mean ± SD) | 10.3 (3.9) | 10.9 (4.0) | 9.8 (3.8) |
% (n) Illiterate | 42.3 (176/417) | 50 (94/189) | 36 (82/228) |
% (n) rural resident | 55.4 (231/417) | 79 (149/189) | 16 (37/228) |
% (n) Sylheti speakers | 45.3 (189/417) | NA | NA |
Bengali Language Skill | Â | Â | Â |
% (n) Can’t speak, read or write | 17 (70/417) | 65.4 (67/189) | 1 (03/228) |
% (n) Can speak only; can’t read or write | 17 (72/417) | 2 (04/189) | 30 (68/228) |
% (n) Can read or write only; can’t speak | 11 (45/417) | 24 (45/189) | - |
% (n) Can speak, read and write | 55 (233/417) | 38.6 (78/189) | 70 (157/228) |
Treatment intensity | Â | Â | Â |
% (n) Oral medication + diet | 65 (272/417) | 60 (114/189) | 69 (158/228) |
% (n) Insulin | 19.4 (81/417) | 23 (44/189) | 16 (37/228) |
% (n) Insulin + oral medication | 15.3 (64/417) | 16 (31/189) | 15 (33/228) |
% reported leisure-time physical activity | 81.3 (339/417 | 86 (162/189) | 78 (177/228) |
Type of co-morbidity | Â | Â | Â |
% (n) Cardiovascular Disease b | 18 (75/417) | 18 (34/189) | 18 (41/228) |
% (n) Hypertension (SBP >140/DBP > 90 mmHg) | 31 (130/417) | 37 (70/189) | 26 (60/228) |
% (n) Others (Kidney/eye problem nephropathy) | 4 (18/417) | 6.3 (12/189) | 3 (06/228) |
SBP [mmHg] (Mean ± SD) | 124 (17) | 127 (19) | 121 (16) |
DBP [mmHg] (Mean ± SD) | 78 (11) | 79 (13) | 76 (10) |
BMI (g/cm2) (Mean ± SD) | 24.5 (4.2) | 24.7 (4.6) | 24.8 (4.5) |
% (n) BMI ≤30 g/cm2 | 68 (283/417) | 69.5 (131/189) | 71 (161/228) |
% (n) BMI > 30 g/cm2 | 32 (134/417) | 30.5 (58/189) | 29 (67/228) |
FBS level (mg/dl) (Mean ± SD) | 154.7 (57.4) | 158.6 (59.3) | 152.4 (52.7) |
HbA1c level (mmol/mol)(Mean ± SD) | 65 (−8) | 67(−7) | 65(−9) |
Age at Diagnosis (Mean ± SD) | 40 (3.3) | 40.3 (3.4) | 39.7 (3.1) |
Duration of Medication [in years] (Mean ± SD) | 13.2 (6.7) | 13.6 (7.3) | 12.9 (6.3) |
Number of medication (Mean ± SD) | 3.8 (1.9) | 3.9 (1.9) | 3.8 (1.8) |
Number of co-morbidity (Mean ± SD) | 1.2 (0.5) | 1.3 (0.5) | 1.2 (0.5) |